Novel ligands for cancer diagnosis: Selection of peptide ligands for identification and isolation of B-cell lymphomas

Experimental Hematology

Volumn 34, Issue 4, 2006, Pages 443-452

  McGuire, Michael J ^a   Samli, Kausar N ^a,c   Chang, Ya Ching ^a   Brown, Kathlynn C ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; LIGAND; PEPTIDE LIBRARY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; BINDING AFFINITY; BONE MARROW; CANCER CELL CULTURE; CELL SELECTION; CELL SPECIFICITY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE CELL; LYMPHOMA CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; LIGANDS; LYMPHOMA, B-CELL; MACROPHAGES; MICE; MICE, INBRED BALB C; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PEPTIDE LIBRARY; PEPTIDES; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 33645244311     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.12.013     Document Type: Article

References (38)

1. American Cancer Society. Cancer statistics presentation 2004. Available at: www.cancer.org. Accessed December 17, 2005.
2. D.G. Maloney, A.J. Grillo-Lopez, and C.A. White IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma Blood 90 1997 2188 2195
3. J.D. Hainsworth, S. Litchy, and H.A. Burris Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma J Clin Oncol 20 2002 4261 4267
4. O.M. Howard, J.G. Gribben, and D.S. Neuberg Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival J Clin Oncol 20 2002 1288 1294
5. B. Marvomatis, and B.D. Cheson Monoclonal antibody therapy of chronic lymphocytic leukemia J Clin Oncol 21 2003 1874 1881
6. G. Cartron, L. Dacheux, and G. Salles Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene Blood 99 2002 754 758
7. W.K. Weng, and R. Levy Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma J Clin Oncol 21 2003 3940 3947
8. G.A. Kennedy, S.K. Tey, and R. Cobcroft Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective study Br J Haematol 19 2002 412 416
9. M.R. Loken, V.O. Shah, K.L. Dattilio, and C.I. Civin Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development Blood 70 1987 1316 1324
10. I. Dervite, D. Hober, and P. Morel Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab N Engl J Med 344 2001 68 69
11. T.H. Westhoff, F. Jochimsen, and A. Schmittel Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy Blood 102 2003 1930
12. S.E. Cwirla, E.A. Peters, R.W. Barrett, and W.J. Dower Peptides on phage: a vast library of peptides for identifying ligands Proc Natl Acad Sci U S A 87 1990 6378 6382
13. M.A. Barry, W.J. Dower, and S.A. Johnston Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries Nat Med 2 1996 299 305
14. K.C. Brown New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries Curr Opin Chem Biol 4 2000 16 21
15. F.D. Hong, and G.L. Clayman Isolation of a peptide for targeted drug delivery into human head and neck solid tumors Cancer Res 60 2000 6551 6556
16. V.V. Ivanenkov, F. Felici, and A.G. Menon Uptake and intracellular fate of phage display vectors in mammalian cells Biochim Biophys Acta 1448 1999 450 462
17. V.V. Ivanenkov, F. Felici, and A.G. Menon Targeted delivery of multivalent phage display vectors into mammalian cells Biochim Biophys Acta 1448 1999 463 472
18. L. Mazzucchelli, J.B. Burritt, and A.J. Jesaitis Cell-specific peptide binding by human neutrophils Blood 93 1999 1738 1748
19. M.J. McGuire, K.N. Samli, S.A. Johnston, and K.C. Brown In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo J Mol Biol 342 2004 171 182
20. M.J. McGuire, K.F. Sykes, and K.N. Samli A library-selected, Langerhans cell-targeting peptide enhances an immune response DNA Cell Biol 23 2004 742 752
21. T. Oyama, K.F. Sykes, K.N. Samli, J.D. Minna, S.A. Johnston, and K.C. Brown Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents Cancer Lett 202 2003 219 230
22. U.B. Rasmussen, V. Schreiber, H. Schultz, F. Mischler, and K. Schughart Tumor cell-targeting by phage-displayed peptides Cancer Gene Ther 9 2002 606 612
23. V.I. Romanov, D.B. Durand, and V.A. Petrenko Phage-display selection of peptides that affect prostate carcinoma cells attachment and invasion Prostate 47 2001 239 251
24. T.I. Samoylova, B.Y. Ahmed, and V. Vodyanoy Targeting peptides for microglia identified via phage display J Neuroimmunol 127 2002 13 21
25. M. Shadidi, and M. Sioud Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells FASEB J 17 2003 256 258
26. J. Zhang, H. Spring, and M. Schwab Neuroblastoma tumor cell-binding peptides identified through random peptide phage display Cancer Lett 171 2001 153 164
27. X. Zhou, Y.C. Chang, T. Oyama, M.J. McGuire, and K.C. Brown Cell-specific delivery of a chemotherapeutic to lung cancer cells JACS 126 2004 15656 15657
28. K.J. Kim, C. Kanellopoulous-Langevin, R.M. Merwin, D.H. Sachs, and R. Asofsky Establishment and characterization of BALB/c lymphoma lines with B cell properties J Immunol 122 1979 549 554
29. L.H. Glimcher, K.J. Kim, I. Green, and W.E. Paul Ia Antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells J Exp Med 155 1982 445 459
30. J.P. Tam Recent advances in multiple antigen peptides J Immunol Methods 196 1996 17 32
31. P. Edman Method for determination of the amino acid sequence in peptides Acta Chem Scand 4 1950 283 293
32. S.F. Altschul, T.L. Madden, and A.A. Schäffer Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res 25 1997 3389 3402
33. T. Ikuta, N. Sogawa, H. Ariga, T. Ikemura, and K. Matsumoto Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family Gene 217 1998 1 13
34. F.S. Jones, and P.L. Jones The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling Dev Dyn 218 2000 235 259
35. K. Matsumoto, Y. Saga, T. Ikemura, T. Sakakura, and R. Ciquet-Ehrismann The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C J Cell Biol 125 1994 483 493
36. M. vonMehren, G.P. Adams, and L.M. Weiner Monoclonal antibody therapy for cancer Annu Rev Med 54 2003 343 369
37. J.D. Isaacs From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies Rheumatology 40 2001 724 738
38. M.E. Reff, K. Carner, and K.S. Chambers Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 83 1994 435 445